STOCK TITAN

Rhythm Pharmaceuticals officer proposes $407K share sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Rhythm Pharmaceuticals, Inc. (RYTM) officer Pamela Cramer reported a proposed sale of 3,520 common shares, with an aggregate market value of $407,017.60 and an approximate sale date of August 10, 2026. Morgan Stanley Smith Barney LLC is named as the broker.

Shares proposed for sale 3,520 common shares Approximate sale date: August 10, 2026
Aggregate market value $407,017.60 Shares proposed for sale
Date acquired August 10, 2026 Acquired through exercise of stock options
Plan adoption or instruction date December 15, 2025 Date listed for Rule 10b5-1 reliance
Aggregate Market Value financial
"Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Exercise of Stock Options financial
"Nature of Acquisition Transaction: Exercise of Stock Options"
Rule 10b5-1 regulatory
"If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RYTM shares did Pamela Cramer propose to sell?

Pamela Cramer reported a proposed sale of 3,520 common shares, with an aggregate market value of $407,017.60. The approximate sale date listed is August 10, 2026.

How did Pamela Cramer acquire the RYTM shares?

Cramer acquired the 3,520 shares from the issuer through an exercise of stock options on August 10, 2026, with cash listed as payment. The notice lists December 15, 2025, as the plan adoption or instruction date for reliance on Rule 10b5-1.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading